Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Yothers

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 16, 2022
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes dataVinicius F Calsavara, Márcio A Diniz, Mourad Tighiouart, et al.
Breast Cancer Research and Treatment|August 21, 2004
Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23Stephanie R Land, Jacek A Kopec, Greg Yothers, et al.
BMC Medical Research Methodology|November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visaeMárcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
The Lancet. Oncology|December 3, 2014
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trialsHans-Joachim Schmoll, Chris Twelves, Weijing Sun, et al.
Cancer|May 10, 2012
Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01Kelley M Kidwell, Greg Yothers, Patricia A Ganz, et al.
Journal of Cancer Survivorship : Research and Practice|June 16, 2009
Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials groupPatricia A Ganz, Stephanie R Land, Cynthia Antonio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatinGreg Yothers, Michael J O'Connell, Mark Lee, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatinGreg Yothers, Alan P Venook, Eiji Oki, et al.
Oncology (Williston Park, N.Y.)|October 19, 2022
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-USIbrahim Halil Sahin, Yan Lin, Greg Yothers, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 16, 2022
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes dataVinicius F Calsavara, Márcio A Diniz, Mourad Tighiouart, et al.
Breast Cancer Research and Treatment|August 21, 2004
Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23Stephanie R Land, Jacek A Kopec, Greg Yothers, et al.
BMC Medical Research Methodology|November 10, 2021
Visualizing adverse events in clinical trials using correspondence analysis with R-package visaeMárcio A Diniz, Gillian Gresham, Sungjin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06Jacek A Kopec, Greg Yothers, Patricia A Ganz, et al.
The Lancet. Oncology|December 3, 2014
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trialsHans-Joachim Schmoll, Chris Twelves, Weijing Sun, et al.
Cancer|May 10, 2012
Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01Kelley M Kidwell, Greg Yothers, Patricia A Ganz, et al.
Journal of Cancer Survivorship : Research and Practice|June 16, 2009
Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials groupPatricia A Ganz, Stephanie R Land, Cynthia Antonio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatinGreg Yothers, Michael J O'Connell, Mark Lee, et al.
Journal of Gastrointestinal Oncology|March 14, 2022
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatinGreg Yothers, Alan P Venook, Eiji Oki, et al.
Oncology (Williston Park, N.Y.)|October 19, 2022
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-USIbrahim Halil Sahin, Yan Lin, Greg Yothers, et al.
Pageof 12